Consulting Offerings for the Life Sciences Industry |
/us_Capsules_200x200_042810.jpg)
|
For life sciences companies, constant upheaval is just business as usual. Pharmaceutical companies, biotechnology firms and medical product, technology and device manufacturers all face the same pressure to innovate in the face of increasing regulations and heightened expectations.
We collaborate with your team to meet current and emerging needs. With the resources necessary to address the wide range of issues affecting business growth for established as well as early-stage and emerging life sciences companies, from inception and incorporation, to an initial public offering or a new global product launch, our professionals have the comprehensive experience that life sciences companies demand to address the assurance, consulting, tax and financial advisory needs of expanding business.
We provide services for our clients in core business operations (sales & marketing, supply chain/ operations, research & development), management (corporate strategy, mergers & acquisitions, profitability improvement, functional/business unit strategy) and infrastructure (finance, IT, HR, real estate). Learn more about the offering.
Featured insights
 |
Global HCP transparency study This report provides guidance for life sciences companies on how to address global HCP transparency challenges.. |
 |
mHealth in an mWorld Report says mobile apps only scratch the surface of possibilities offered by mHealth. Improvement opportunities exist along the value chain, from engaging patients to maximizing provider productivity to controlling costs. |
 |
10 myths of health care reform Health care reform is complex: its issues are complicated and solutions in some cases are not clear. This infographic covers ten myths about health care reform. |
 |
Full Disclosure Ahead: A roundtable discussion on HCP transparency Read the report. |
 |
Moving Toward the Light The Physician Payment Sunshine Provision of the PPACA unprecedented transparency requirements presents some very challenging and complex operational requirements. |
Case studies
Finance Transformation in Pharmaceuticals - From the F Troop to the 82nd Airborne
Could the finance function continue to lead business value and responsiveness – and improve efficiency at the same time?
Finance Transformation in Pharmaceuticals: When the Party's Over
After years of record growth, declining profitability forced this large pharmaceutical company to increase its focus on efficiency and costs.
Human Capital Transformation Helps Multinational Pharmaceutical Companies Through Merger
Creating a comprehensive approach to human capital management.
Life Sciences Company Seeks Improved HR Service Delivery
Developing and implementing a new Human Resources Service Delivery Model.
Life Sciences company seeks relief from growing pains, finds immediate $40 Million in Savings
Enterprise cost reduction in the medical device industry.
Our Life Sciences offerings
- Commercial Transformation
- R&D Transformation
- Health Informatics
- Preconfigured SAP Solutions for Life Science
- Preconfigured Oracle Solution for Life Science
- Radical Cost Reduction
Meet our people
- Gregory Reh, Principal, Deloitte Consulting LLP
- Scott Evangelista, Principal, National Commercial Practice Leader, Deloitte Consulting LLP
- Theresa Cooper, Principal, Deloitte Consulting LLP and National Leader, Life Sciences R&D Practice
- Jacques Mulder, Principal, Pharmaceutical R&D Practice Leader, Deloitte Consulting LLP
- Scott Sopher, Principal, Deloitte Consulting LLP
